本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

63.48
+0.97001.55%
盤後62.91-0.5700-0.90%16:50 EDT
成交量:221.99萬
成交額:1.41億
市值:59.84億
市盈率:-133.24
高:64.07
開:62.58
低:62.41
收:62.51
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:1.59
換手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:244.01
市盈率(LYR):-221.69

資料載入中...

2023/07/17

重要事件披露

Form 8-K - Current report
2023/06/01

重要事件披露

Form 8-K - Current report
2023/05/22

重要事件披露

Form 8-K - Current report
2023/05/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/10

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/10

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

重要事件披露

Form 8-K - Current report
2023/04/12

重要事件披露

8-K - Current report
2023/03/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/03/01

重要事件披露

8-K - Current report
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/17

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals